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ABSTRACT 
Meso-diaminopimelate decarboxylase 
catalyzes the decarboxylation of meso-
diaminopimelate, the final reaction in the 
diaminopimelate L-lysine biosynthetic pathway. 
It is the only known pyridoxal-5-phosphate-
dependent decarboxylase that catalyzes the 
removal of a carboxyl group from a D-
stereocenter. Currently, only prokaryotic 
orthologs have been kinetically and structurally 
characterized. Here, using complementation and 
kinetic analyses of enzymes recombinantly 
expressed in Escherichia coli, we have 
functionally tested two putative eukaryotic 
meso-diaminopimelate decarboxylase isoforms 
from the plant species Arabidopsis thaliana. We 
confirm they are both functional meso-
diaminopimelate decarboxylases, although with 
lower activities than those previously reported 
for bacterial orthologs. We also report in-depth 
X-ray crystallographic structural analyses of 
each isoform at 1.9 and 2.4 Å resolution. We 
have captured the enzyme structure of one 
isoform in an asymmetric configuration, with 
one ligand-bound monomer and the other in an 
apo form. Analytical ultracentrifugation and 
small-angle X-ray scattering solution studies 
reveal that A. thaliana meso-diaminopimelate 
decarboxylase adopts a homo-dimeric assembly. 
On the basis of our structural analyses, we 
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suggest a mechanism whereby molecular 
interactions within the active site transduce 
conformational changes to the active-site loop. 
These conformational differences are likely to 
influence catalytic activity in a way that could 
allow for D-stereocenter selectivity of the 
substrate meso-diaminopimelate, to facilitate the 
synthesis of L-lysine. In summary, the A. 
thaliana gene loci At3g14390 and At5g11880 
encode functional meso-diaminopimelate 
decarboxylase enzymes whose structures 
provide clues to the stereochemical control of 
the decarboxylation reaction catalyzed by these 
eukaryotic proteins.  
 
 
Stereochemical control of catalysis is a 
hallmark feature of enzymes. By restricting 
substrate accessibility and guiding substrate 
binding orientation, enzymes precisely dictate 
substrate specificity and product 
stereochemistry. For example, in the bacterial 
type I polyketide synthases, the stereochemical 
outcome of the native substrate can be predicted 
simply by the presence of particular sequence 
motifs within the catalytic domain (1). Similarly, 
mutation studies have shown that the formation 
of different stereoisomers by heteroyohimbine 
synthase appear to be determined solely by a 
single histidine residue positioned in an active 
site loop (2). 
In organisms that use the 
diaminopimelate pathways for the synthesis of 
lysine, the final step is the decarboxylation of 
meso-diaminopimelate to produce L-lysine and 
carbon dioxide (3,4). This reaction is catalyzed 
by the enzyme meso-diaminopimelate 
decarboxylase (DAPDC). The substrate of the 
reaction, meso-diaminopimelate, features two 
carboxylate groups located at two different 
stereocenters; one is an L-stereocenter, while the 
other is a D-stereocenter. Decarboxylation of 
meso-diaminopimelate specifically at the D-
stereocenter results in the production of L-lysine 
(Fig. 1).   
The specificity toward the D-
stereocenter of the substrate is a feature unique 
to DAPDC, as all other pyridoxal-5-phosphate 
(PLP) dependent decarboxylases characterized 
thus far act on L-stereocenters (3). Crystal 
structures of bacterial DAPDC enzymes reveal 
that these proteins have an optimal substrate 
binding pocket to accommodate the substrate, 
meso-diaminopimelate, and present the D-
stereocenter for decarboxylation (5–9). The 
mechanism by which this stereo-specificity is 
achieved in eukaryotic orthologs remains 
uncertain. 
DAPDC is a member of the alanine 
racemase family of fold-type-III PLP-dependent 
enzymes. This family also includes the ornithine 
and arginine decarboxylases (10). Within the 
active site of these enzymes, the aldehyde 
moiety of the PLP cofactor is covalently bound 
to a conserved lysine residue forming a Schiff 
base (also referred to as an internal aldimine). 
Upon binding of the substrate, the lysine residue 
is exchanged for the amino group of the 
substrate forming an external aldimine. In the 
reaction catalyzed by DAPDC the bond between 
the ɑ-carbon of the external aldimine and the 
carboxylate group is broken. PLP facilitates the 
reaction by withdrawing electron density from 
the substrate through a series of double bonds 
conjugated to the cationic pyridinium ring, 
stabilizing the negative charge that develops on 
the substrate during the reaction (10). 
DAPDC is an attractive and putative 
target for the rational design of herbicides given 
the fact that the enzyme catalyzes a reaction that 
is essential for the anabolism of one of the 20 
ubiquitous proteogenic amino acids. In addition, 
it is plausible that herbicides that specifically 
inhibit DAPDC will not be toxic to humans and 
animals in general since the DAPDC and lysine 
anabolic pathways are absent in the animal 
kingdom.  
Our current understanding of the 
structure and function of DAPDC is largely 
based on work conducted on archaeal and 
bacterial orthologs from Methanococcus 
jannaschii (9), Mycobacterium tuberculosis 
(7,8), Helicobacter pylori (5) and 
Corynebacterium glutamicum (6). Previous 
findings suggest that DAPDC is a dimer in 
solution, although a tetrameric assembly has 
been observed in the asymmetric unit of crystal 
structures of M. tuberculosis, and small-angle X-
ray scattering data suggest a weak dimer-
tetramer equilibrium (8). More recently, solution 
studies using analytical ultracentrifugation and 
small-angle X-ray scattering coupled with 
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enzyme kinetics have concluded that DAPDC 
enzymes from a range of bacterial species form 
dimers in solution (11). It appears that 
dimerization is required for catalysis due to the 
contribution of residues to the active site from 
both subunits. Consequently, disrupting self-
association may provide a means to inhibit these 
enzymes. Thus far, the only studies that have 
been reported for a eukaryotic DAPDC are of 
the two Arabidopsis thaliana orthologs that were 
initially identified and verified through a 
functional complementation assay (12). 
Preliminary structural studies have been carried 
out on these orthologs, but the quaternary 
association has not yet been investigated (13).  
Here we report the X-ray 
crystallographic structures of two DAPDC 
isoforms from the plant species A. thaliana; the 
first in-depth structural characterization of 
eukaryotic orthologs. Functional 
complementation studies and kinetic analyses 
reveal that these isoforms are both authentic 
DAPDC enzymes, while analytical 
ultracentrifugation and small-angle X-ray 
scattering solution studies reveal that the protein 
adopts a homo-dimeric assembly. We 
successfully solved the structure of one of the A. 
thaliana isoforms in an asymmetric 
arrangement, with one active site loop in the 
open position and the other closed. These novel 
observations provide new insight into the 
catalytic mechanism, giving clues as to how this 
enzyme exerts stereochemical control of the 
decarboxylation reaction. 
 
 
RESULTS AND DISCUSSION 
Complementation analysis of an E. coli lysine 
auxotrophic mutant demonstrates that At-
DAPDC1 and At-DAPDC2 can rescue 
endogenous lysine biosynthesis 
To assess whether the identified genes 
annotated by the locus tags At3g14390 and 
At5g11880 are functional DAPDC enzymes, 
complementation analyses were conducted. The 
E. coli CGSC strain #10193 harbors a mutation 
in the gene that encodes for DAPDC (lysA). This 
mutation results in a lysine auxotrophic 
phenotype where the mutant is able to grow only 
in the presence of exogenous lysine. As such, we 
can test the functionality of At-DAPDC enzymes 
by whether or not they can functionally 
complement the lysA mutant. It should be noted 
that previous work by our group shows that both 
At-DAPDC isoforms were able to complement 
another lysA mutant in a study that surveyed the 
lysine anabolic genes from A. thaliana (12). 
However, the previous analysis used full-length 
cDNAs for both proteins whereas the analysis 
reported here was completed without the 
sequences that encode the predicted transit 
peptide that denotes localization to the 
chloroplast (13).  
To ascertain whether the genes of 
interest are able to complement the E. coli lysA 
mutation, mutants were transformed with an 
empty vector (pBAD33) or with pBAD33 
expressing At-DAPDC1 or At-DAPDC2. The 
plasmid pBAD33 possesses a promoter that is 
inducible in the presence of arabinose and 
repressible in the presence of glucose (14). 
Surprisingly, both At-DAPDC enzymes were 
only able to rescue the mutant when their 
expression was repressed by glucose (Fig. 2). It 
is believed that under this condition there is still 
enough basal expression to allow for the 
synthesis of adequate quantities of lysine for 
protein synthesis to facilitate growth.  
Conversely, in cells in which the 
expression of At-DAPDC is enhanced (in the 
presence of arabinose), no growth was seen (Fig. 
2). Rather than this being due to a lack of lysine 
production to facilitate protein synthesis, we 
propose that this result is due to the depletion of 
meso-diaminopimelate, the substrate of DAPDC. 
In Gram-negative bacteria, such as E. coli, 
meso-diaminopimelate is used as the cross-
linking amino acid in the peptide stem of 
peptidoglycan, a process facilitated by meso-
diaminopimelate ligase (MurE) (15). Therefore, 
the induced expression of At-DAPDC enzymes 
in lysine-free media leads to cell death because 
the native MurE cannot compete with the 
overexpressed DAPDC and thus, while the 
organism is able to synthesize L-lysine, it has 
impaired peptidoglycan synthesis. Nonetheless, 
these results indicate that the two genes encode 
authentic DAPDC enzymes and are able to 
function in E. coli without the predicted 
chloroplast transit peptide sequences.  
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Recombinant At-DAPDC1 and At-DAPDC2 
are both enzymatically active 
Although both enzymes are active, their 
rate of turnover is surprisingly low. The catalytic 
activities of recombinant At-DAPDC1 and At-
DAPDC2 were examined using the DAPDC-
SDH coupled assay (16). We first determined 
that the rate of catalysis was linear across an 
enzyme concentration range of 0-800 nM (Fig. 
3A). We therefore chose to collect the initial rate 
data at an enzyme concentration of 550 nM. The 
initial rate data for both enzymes fitted well to 
the Michaelis-Menten equation (Fig. 3B and C). 
The purified At-DAPDC enzymes are both 
catalytically active with apparent Km values of 
5.1 and 4.8 mM, Vmax values of 85 and 229 nmol 
min-1, and catalytic rate constants (kcat) of 0.005 
and 0.014 s-1, for At-DAPDC1 and At-DAPDC2, 
respectively (Table 1). The Km values are 
consistent with other previously characterized 
DAPDC enzymes [0.68 mM (Bacillus 
anthracis), 0.97 mM (E. coli), 1.6 mM (M. 
tuberculosis) and 1.9 mM (Vibrio cholerae) 
(11)]. On the other hand, the catalytic rate 
constants for the A. thaliana DAPDC orthologs 
are much lower than their bacterial counterparts 
[58 s-1 (B. anthracis), 55 s-1 (E. coli), 28 s-1 (M. 
tuberculosis) and 22 s-1 (V. cholerae) (11)]. This 
may be a reflection of the lower temperatures 
used here (30 °C, compared to 37 °C). Peverelli 
et al. (11) found that dimerization of DAPDC 
was required for catalysis, given that residues 
are required from each subunit to form the active 
site. Therefore, we sought to investigate the 
quaternary structure of the recombinant At-
DAPDC enzymes in solution. 
 
At-DAPDC enzymes exist in a monomer-dimer 
equilibrium 
While monomeric (5,17), dimeric 
(6,7,9) and tetrameric (8) assemblies have been 
observed in crystal structures of prokaryotic 
orthologs of DAPDC, the quaternary structure 
has not yet been investigated for any plant 
orthologs. To address this, the quaternary 
structure of the two At-DAPDC enzymes were 
characterized by analytical ultracentrifugation. 
Sedimentation velocity data were fitted to 
continuous size distribution models yielding c(s) 
distributions (Fig. 4). For both proteins (at 
concentrations between 5 and 20 µM) two 
species with sedimentation coefficients of 
around 3.5 and 5 S are evident in solution. When 
fitted to a continuous mass distribution model, 
the estimated masses of each species are ~50 
and ~100 kDa (based on frictional ratios of 1.51 
for At-DAPDC1 and 1.43 for At-DAPDC2, 
calculated during the c(s) analyses); therefore, 
these peaks correspond to a monomer and dimer 
(given the theoretical monomeric molecular 
weights of 53,807 for At-DAPDC1 and 54,240 
Da for At-DAPDC2).  
The plots in Fig. 4 (A and B) have been 
normalized to the height of the peak 
corresponding to the dimer, revealing that with 
increasing protein concentration the proportion 
of protein found in the dimeric form increases. 
This indicates that the protein is in a 
concentration-dependent monomer-dimer self-
association. The sedimentation velocity data was 
further analyzed using the advanced van-
Holde/Weischet method. This method is model-
independent and directly assesses the shape of 
the sedimenting boundary to provide an estimate 
of the proportion of each species in solution 
(Fig. 4, C and D). The half-parabolic shape of 
the van-Holde/Weischet plots are characteristic 
of mass action and support the conclusion that 
this protein exists in equilibrium between its 
monomeric and dimeric forms. 
The predominant species at these 
concentrations is the dimer, suggesting that the 
dimer dissociation constants (KD2-1) for these 
enzymes are below the concentrations examined 
here. Sedimentation velocity data at the lowest 
concentration (5 µM) were fitted to a monomer-
dimer model. These analyses estimate the KD2-1 
values for both At-DAPDC enzymes to be less 
than 1 µM (Table 2). The enzyme assays were 
conducted at a concentration of 550 nM, thus 
there is likely a mixture of monomers and dimer 
in solution at this concentration. However, since 
the rate vs. enzyme concentration (Fig. 3A) is 
linear from 200-800 nM, which spans the 
estimated KD2-1 for both enzymes (~650 nM), 
either both the monomer and dimer are similarly 
active, or the presence of substrates lowers the 
dissociation constant, resulting in a 
predominantly dimeric species at the 
concentration used to collect the initial rate data.  
Given the results of Peverelli et al. (11), where 
mutants that disrupt the dimer interface of V. 
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cholerae DAPDC have attenuated activity, we 
suggest that the latter is a more reasonable 
explanation of the data. 
 
Structural characterization of At-DAPDC 
enzymes 
At-DAPDC1 and At-DAPDC2 were 
crystallised as previously reported (13). All 
relevant data-collection and processing 
parameters are given in Table 3. Globally, the 
structures of the two At-DAPDC enzymes show 
considerable similarity to each other and to 
previously characterized bacterial DAPDC 
enzymes (Fig. S1) (5–9). For both structures, the 
asymmetric unit is a dimer (Fig. 5A), with each 
monomer comprising of two domains; an 
alanine racemase-like fold and an (α/β)8 barrel 
domain (Fig. 5B). The alanine racemase-like 
domain (shown in yellow, Fig. 5B) is composed 
of interlocking β-strands from both the N- and 
C-termini (residues 1-50 and 301-440, amino 
acid numbering corresponding to that of At-
DAPDC1). The (α/β)8 barrel domain (residues 
51-300, shown in red in Fig. 5B) contains the 
active site at its core and features an extended 
active site loop between the fifth β-sheet (β5) 
and sixth α-helix (α6) of the barrel (residues 
165-194). The monomers associate in a head-to-
tail arrangement to form a dimer, with the two 
active sites located at the dimer interface. 
To validate that the dimeric assembly 
observed in the crystal structures is an accurate 
representation of the protein structures in 
solution, small-angle X-ray scattering 
experiments were conducted. The structural 
parameters obtained from these analyses are 
summarised in Table 4. The maximum 
dimensions of the particles (105 and 113 Å for 
At-DAPDC1 and At-DAPDC2) and estimated 
molecular weights (95 and 94 kDa) are most 
consistent with that of a dimer (given the 
theoretical dimeric molecular weights of 107 
and 108 kDa for At-DAPDC1 and At-DAPDC2). 
Further, theoretical scattering curves were 
generated based on the crystal structures of At-
DAPDC for both a monomer and a dimer. The 
experimental scattering obtained for samples of 
At-DAPDC in solution are a much closer fit to 
the scattering calculated for a dimer than for a 
monomer (Χ2 = 0.41 and 0.71, compared to 3.26 
and 8.09), suggesting that the dimeric quaternary 
arrangement observed in the crystal structures 
are correct (Fig. 5, C and D). 
 
The active sites of At-DAPDC enzymes are 
similar to prokaryotic orthologs of DAPDC 
In the structure of At-DAPDC1, electron 
density consistent with the structure of a PLP 
molecule can be observed in both active sites 
(Fig. 6A). The density is continuous with a free 
lysine molecule, probably resulting from the 
supplementation of free lysine in the 
crystallization conditions. This external aldimine 
is likely to closely reflect the catalytic 
intermediate formed between meso-
diaminopimelate and PLP during the 
decarboxylation reaction (5). PLP is positioned 
near a conserved lysine residue (Lys77) that 
likely forms the internal aldimine with PLP 
when no substrate is present. In contrast, in the 
structure of At-DAPDC2, electron density 
attributable to PLP and a molecule of free lysine 
is visible in one active site only (Fig. 6B). No 
such electron density is observed in the other 
active site. 
The same interactions are present in the 
PLP-bound active sites of At-DAPDC1 and At-
DAPDC2 (see LigPlot in Fig. S2). For the 
following analyses, residue numbering 
according to At-DAPDC2 is used, to allow for 
comparisons to be made between the ligand 
bound and apo monomers. PLP forms hydrogen 
bonds directly with Ser223, Arg299, Tyr396, Gly298, 
Gly260, Glu296 and via water molecules with 
Leu261, Arg299, Ser300, Arg169 and Cys367* (the 
asterisk denotes that this residue is contributed 
from the opposing monomer) (Fig. 6C). His220 is 
positioned parallel to PLP, approximately 3.5 Å 
above the aromatic ring of the cofactor, 
appropriately positioned to facilitate a π-
stacking interaction (Fig. 6C). The supplemented 
lysine molecule forms hydrogen bonds with 
Arg299, Arg335, Tyr339 and Glu368* (Fig. 6D).  
The active site architecture described 
here for the A. thaliana orthologs of DAPDC is 
similar to that observed in previously 
characterized bacterial orthologs (5–9), 
suggesting that eukaryotic DAPDC enzymes 
employ the same methods to direct 
stereochemical control. This includes anchoring 
of the L-stereocenter of meso-diaminopimelate 
presenting the D-stereocenter for catalysis, 
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facilitated by the conserved residues Arg299, 
Arg335, Tyr339 and Glu368* (see Fig. S3 for 
sequence alignment). This also includes the 
contribution of residues from both subunits 
toward the active site, suggesting that, as in 
bacterial orthologues (11), the dimer is the 
catalytically active form.  
 
Conformational differences between 
the apo and PLP-bound monomers of At-
DAPDC2 provide insight into stereochemical 
control 
The PLP-bound monomer of At-
DAPDC2 shows distinct conformational 
differences to the apo monomer (without PLP 
and lysine). When superimposed, the rmsd value 
is 0.456, compared to 0.128 when aligning the 
two monomers of At-DAPDC1 (both PLP-
bound). This is the first time an asymmetric 
dimer has been observed in a structure of 
DAPDC, and may give further insight into the 
stereochemical control of the decarboxylation 
reaction mediated by DAPDC. 
One such conformational difference 
between the apo and PLP-bound forms is the 
position of the active site loop. The active site 
loop is the region between Arg169 and Lys197 
(numbering according to At-DAPDC2) that 
extends past the entrance to the active site (Fig. 
7). The electron density of this region is often 
poorly defined in structures of DAPDC (5), 
owing to the flexibility of this loop. Similarly, 
density was absent and could not be modelled 
for sections of the active site loop in chain B of 
At-DAPDC1 (residues 170-180, green loop in 
Fig. 7A) and chain A of At-DAPDC2 (residues 
180-188, blue loop in Fig. 7B). By comparing 
the positions of residues at each end of the loop 
(for which there is clear density), a significant 
change in the position of the loop becomes 
apparent between the apo and PLP-bound forms 
of At-DAPDC2 (Fig. 7B). The loop is in an open 
conformation in the apo form, while it is closed 
in the PLP-bound form. This can be seen most 
clearly when observing residue Phe191; in the 
PLP-bound monomer (green loop) this 
phenylalanine residue lies near the edge of the 
active site (shown by the purple PLP molecule). 
Conversely, in the apo monomer (blue loop), 
Phe191 is shifted by 19 Å and is buried in the 
interface between the α7 and α8 helices of the 
(α/β)8 barrel. Interestingly, judging by the 
position of this phenylalanine residue, all 
structures of DAPDC orthologs currently 
deposited in the PDB appear to have loops in the 
closed conformation. 
In the active site of the apo monomer of 
At-DAPDC2, several differences can be 
observed compared to the PLP-bound active site. 
Most of these involve reorientations of side 
chains that are no longer bound by hydrogen 
bonds to either PLP or lysine. However, some 
residues undergo more significant 
conformational change, including Arg169, His218 
and His220 (Fig. 7C). In the apo form, Arg169 
exists in a twisted conformation, forming a 
hydrogen bond with Asp145. His218 and His220 are 
located in close proximity facing towards Arg169. 
In the PLP-bound form, His220 is reoriented to 
form a π-stacking interaction with PLP, while 
His218 fills the space vacated by His220. Arg169 
adopts an extended conformation running 
parallel to His220 and His218 that is stabilized 
through a hydrogen bond with the backbone 
carbonyl of His220. This constitutes a 2.5 Å 
movement of the Cα atom of Arg169. Arg169 is 
the first residue of the active site loop, thus it is 
conceivable that this conformational 
rearrangement may be associated with 
repositioning of the active site loop into the 
closed configuration. 
Closure of the active site loop has been 
shown to enhance the rate of catalysis in 
DAPDC from H. pylori (5). As well as 
stabilizing the catalytic intermediate, closure of 
the active site loop may be important in 
excluding other molecules from entering the 
active site, preventing side reactions, or 
excluding water from the active site during the 
course of the reaction; in so doing, this may 
enhance catalysis as production of the non-polar 
product, CO2, would be expected to occur faster 
in a nonpolar environment than surrounded by 
water. 
When meso-diaminopimelate is 
modelled in the active site of At-DAPDC2 in the 
same configuration as L-lysine (shown in yellow 
in Fig. 7D), the D-stereocenter carboxyl can be 
suitably accommodated within the active site, 
while steric hindrance (with Cys367 and Glu368) 
would prevent binding in the reverse orientation. 
In this configuration, we can also see a possible 
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hydrogen bond between the substrate and His220 
(within 3 Å of each other). It is possible, 
therefore, that approach of the substrate is able 
to stabilize the position of His220 over the 
pyridoxal ring, and subsequently encourage the 
closure of the active site loop, but this would 
occur only when the D-stereocenter is oriented 
for decarboxylation, not the L-stereocenter. If 
active site loop closure is required to enhance 
catalysis in At-DAPDC, as it does in H. pylori 
(5), this may provide an extra means by which 
DAPDC exerts stereochemical control over the 
decarboxylation of meso-diaminopimelate.   
 
Conclusion 
We have established that the A. thaliana 
gene loci, At3g14390 and At5g11880, encode 
functional DAPDC enzymes. The recombinantly 
expressed, eukaryotic enzymes are catalytically 
active, but exhibit much lower activity than 
previously characterized bacterial orthologs. To 
determine whether this is a feature of plant 
DAPDC enzymes will require further 
characterization of eukaryotic DAPDC 
orthologs. Solution studies reveal that both At-
DAPDC enzymes exist in a monomer-dimer 
equilibrium in solution, however, the dimer is 
likely the catalytically active form due to the 
requirement of residues from each subunit to 
form the active site. This is in line with 
previously characterized bacterial orthologs of 
DAPDC. 
The crystal structures of the At-DAPDC 
enzymes reveal that the eukaryotic orthologues 
characterized here for the first time are very 
similar structurally, including the active site 
architecture, to the prokaryotic forms of DAPDC 
previously characterised. The fortuitous capture 
of At-DAPDC2 in an asymmetric dimer, with 
one monomer in the apo form and the other in a 
ligand-bound form, provides valuable insight 
into the conformational transition that occurs 
upon PLP binding. Furthermore, this is the first 
DAPDC structure that has the active site loop in 
an open conformation. 
Based on our structural data, we propose 
that the following conformational changes are 
important for catalysis and stereochemical 
selection of the substrate. Firstly, binding of 
PLP initiates rearrangements within the active 
site, specifically the reorientation of Arg169, 
His218 and His2220. These conformational 
changes are propagated to the active site loop, 
through Arg169 which is a part of this loop; the 
position of the active site loop is known to 
influence the catalytic activity of DAPDC 
enzymes (5). Secondly, we have shown that the 
substrate, meso-diaminopimelate, is positioned 
through interactions with conserved active site 
residues to form an additional hydrogen bond to 
His220. This further stabilizes the closed active 
site loop conformation, mediated through Arg169, 
and can only occur when the D-stereocenter is 
oriented for decarboxylation. These findings 
provide further clues into how DAPDC targets 
the D-stereocenter of the substrate, meso-
diaminopimelate, for decarboxylation during 
catalysis—knowledge that is necessary to assist 
in the design of effective inhibitors that may act 
as herbicides or antibiotics. 
 
EXPERIMENTAL PROCEDURES 
Cloning of the cDNAs annotated by the locus 
tags At3g14390 and At5g11880  
The cDNAs At3g14390 (At-DAPDC1) 
and At5g11880 (At-DAPDC2), encoding the two 
isoforms of DAPDC from A. thaliana, were 
cloned as previously described (13). The 
forward and reverse primers used to amplify the 
At3g14390 cDNA were 5’-
CCCCCGGATCCATGGCCGCCGTCGTTTCT
CAAAACTCGTCC-3’ and 5’-
CCCCCGTCGACTCATAGACCTTCAAAGA
AACGCAAATGGTC-3’. The forward and 
reverse primers used to amplify the At5g11880 
cDNA were 5’-
CCCCCGGATCCATGGCCGCCGTTTCCCAA
AACTCCTACCAAA-3’ and 5’-
CCCCCGTCGACTCATAGTCCTTCAAAGAA
ACGTAAATGGTC-3’. The underlined 
nucleotides represent the restriction enzyme sites 
used in the cloning of the cDNAs, while the bold 
and italicized nucleotides represent initiation and 
termination codons. The PCR protocols were 
designed to exclude the first 144 and 147 
nucleotides from the At3g14390 and At5g11880 
cDNAs, respectively, as these nucleotides 
encode a predicted transit peptide that allows 
localization to the chloroplast. The truncated 
cDNAs were cloned between the BamH1 and 
Sal1 restriction sites of pET30A to produce the 
plasmids pET30a::At3g14390 and 
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pET30a::At5g11880. The constructs have the 
following amino acid residues 
(MHHHHHHSSGLVPRGSGMKETAAAKFDR
QHMDSPDLGTDDDDKAMADI) at the N-
terminus end of each recombinant enzyme, 
yielding polypeptides of 53,807 Da (At-
DAPDC1) and 54,240 Da (At-DAPDC2).  
 
Functional complementation 
The plasmids used for functional 
complementation were produced by sub-cloning 
the XbaI and SalI fragment from 
pET30a::At3g14390 and pET30a::At5g11880 
into pBAD33 (14), to produce the plasmids 
pBAD33::At3g14390 and pBAD33::At5g11880. 
The proteins produced from the pBAD33 
constructs are identical to the proteins produced 
from the pET30a constructs. 
An Escherichia coli lysine auxotrophic 
mutant (CGSC strain #10193: [∆(araD-araB) 
567, ∆lacZ4787 (::rrnB-3), λ-,∆lysA763::kan, 
rph-1, ∆(rhaD-rhaB) 568, hsdR514] (18)) was 
transformed with either the empty pBAD33 
vector, pBAD33::At3g14390 or 
pBAD33::At5g11880. Colonies were selected on 
Luria-Bertani (LB) agar plates supplemented 
with 34 μg mL-1 chloramphenicol and 50 μg mL-
1 kanamycin. Individual colonies were then 
replica-plated onto M9 medium supplemented 
with 0.5% (w/v) glycerol, with or without 50 μg 
mL-1 lysine, and 0.2% (w/v) arabinose or glucose. 
The colonies were incubated at 30 °C for 48 
hours. 
 
Protein expression and purification of At-
DAPDC for structural characterization 
The expression vectors 
pET30a::At3g14390 and pET30a::At5g11880 
were transformed into E. coli Rosetta (DE3) 
cells. The transformed cells were grown in LB 
medium (with 50 μg mL-1 kanamycin and 34 μg 
mL-1 chloramphenicol) at 37 °C until the OD600 
reached approximately 0.5. Expression at 26 °C 
overnight was induced by addition of 0.5 mM 
isopropyl-D-1-thiogalactopyranoside (IPTG). 
The cell pellet was resuspended in 
buffer (50 mM sodium phosphate, 300 mM 
sodium chloride, 10 mM imidazole, pH 8.0) and 
lysed by sonication using a cell disruptor (Vibra-
Cell VC 750; Sonics). The lysate was clarified 
by centrifugation (12,000 g, 4 °C, 10 min) and 
loaded onto a GE Healthcare His-Trap FF Crude 
5 mL column (GE Healthcare). The bound His-
tagged protein was eluted with increasing 
imidazole concentration up to 250 mM. 
Fractions containing protein were pooled and 
concentrated to 3 mL using a 30 kDa molecular-
weight cut-off spin concentrator (Vivaspin 
centrifugal concentrator, Sartorius). The 
concentrated solution was further purified on a 
HiLoad 10/30 Superdex 200 column (GE 
Healthcare) pre-equilibrated with buffer (20 mM 
Tris, 100 mM sodium chloride, pH 8.0). All 
purification steps were carried out at 4 °C. Peak 
fractions were concentrated to 10 mg mL-1 using 
a 30 kDa molecular-weight cut-off spin 
concentrator. Protein concentrations were 
determined spectrophotometrically using the 
extinction coefficient at 280 nm of 33,350 M-
1cm-1, calculated from amino acid sequences 
using ExPASy ProtParam (19), and Beer’s law 
(20). 
 
Protein expression and purification of At-
DAPDC and Sc-SDH for enzymatic assays 
 pET30a::At3g14390, 
pET30a::At5g11880 and pET16b::ScLys1 
(expressing saccharopine dehydrogenase from 
Saccharomyces cerevisiae) were transformed 
into E. coli BL21-CodonPlus-RIPL strain 
(Agilent Technologies, USA). Cells were grown 
in LB media containing 50 μg mL-1 kanamycin 
and 34 μg mL-1 chloramphenicol (At-DAPDC) 
or 50 μg mL-1 ampicillin and 34 μg mL-1 
chloramphenicol (Sc-SDH) at 37 °C, to an OD600 
of 0.5. Protein expression was induced with 1.0 
mM IPTG for 24 hours at 18 °C. The cells were 
lysed by sonication in a solution of 50 mM 
sodium phosphate (pH 8.0) and 300 mM sodium 
chloride. The extract was incubated with Talon 
Metal Affinity Resin (Clontech, Mountain View 
CA, USA) for 30 min at 4 °C. The resin was 
washed five times with sonication buffer 
containing 10 mM imidazole (pH 8.0), and the 
enzyme was eluted with buffer containing 250 
mM imidazole. The pure protein was 
concentrated in an Amicon Ultra 10,000 
molecular-weight cut-off spin concentrator 
replacing the elution buffer with 100 mM Tris 
containing 1 mM DTT and 2 mM EDTA (pH 
8.0). Protein concentration was determined by 
the Bradford assay (21). 
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DAPDC kinetic assay 
A coupled assay, using Sc-SDH as the 
coupling enzyme, was used to measure the 
activity of At-DAPDC1 and At-DAPDC2 (16). 
L-lysine produced from meso-diaminopimelate 
by DAPDC is used as the substrate of Sc-SDH 
along with α-ketoglutarate and NADH. The 
oxidation of NADH to NAD+ can be monitored 
spectrophotometrically as a decrease in the 
absorbance at 340 nm over time. 
Titration assays varying the 
concentration of substrate, meso-
diaminopimelate, were buffered with 100 mM 
Tris (pH 8.0) using a final assay concentration of 
200 μM NADH, 25 mM α-ketoglutarate and an 
excess of Sc-SDH (40 μg). With a final reaction 
volume of 500 μL, meso-diaminopimelate was 
added to various final concentrations ranging 
from 0 to 15 mM. Reactions were initiated with 
the addition of either At-DAPDC1 or At-
DAPDC2 to a final concentration of 550 nM. All 
coupled assays were performed at 30 °C and 
absorbance at 340 nm was measured as a 
function of time. Data were analysed using a 
Michaelis-Menten kinetic model to determine 
the Vmax, Km and kcat. 
 
Analytical ultracentrifugation 
Sedimentation velocity experiments 
were performed in a Beckman Coulter XL-I 
analytical ultracentrifuge. Sedimentation was 
monitored using the absorbance optical system. 
At-DAPDC1 and At-DAPDC2 were analysed at 
three protein concentrations: 5, 10 and 20 µM in 
20 mM Tris, 150 mM sodium chloride at pH 8.0. 
Sample solutions were loaded into 12 mm 
double-sector quartz cells and centrifuged at 
50,000 rpm at 20 °C. Intensity data were 
recorded over a radial position range of 6.0 to 
7.25 cm, with a step size of 0.003 cm. Different 
wavelengths were monitored depending on the 
protein concentration; 281 nm was used for 20 
µM samples, while lower concentrations were 
analysed at 236 nm. 
The sedimentation data were fitted to a 
continuous size-distribution model in SEDFIT 
(22) using the partial specific volume of At-
DAPDC and the solvent viscosity and density 
computed in SEDNTERP (23). Two-dimensional 
spectrum analyses with 50 Monte Carlo 
iterations and enhanced van-Holde/Weischet 
analyses were conducted in UltraScan III (24–
26). The data were fitted to a reversible 
monomer-dimer model with genetic algorithm 
optimization (27). 96 Monte Carlo iterations 
were performed in each genetic algorithm fit to 
determine the 95% confidence intervals for each 
parameter. During fitting the monomer 
molecular weight was fixed at the molecular 
weight derived from the protein sequence (53.8 
kDa for At-DAPDC1 and 54.2 kDa for At-
DAPDC2).  
 
X-ray crystallography 
Purified At-DAPDC1 and At-DAPDC2 
were crystallized and X-ray diffraction data 
collected as previously reported (13). The crystal 
structures were refined using REFMAC (28) 
with iterative rounds of model building 
performed in COOT (29). The structures were 
deposited into the Protein Data Bank (PDB) and 
assigned PDB ID’s of 6N2A and 6N2F. 
 
Small-angle X-ray scattering 
Data was collected at the SAXS/WAXS 
beamline at the Australian Synchrotron Facility 
using a 1M Pilatus detector. The two protein 
samples were injected at 10 mg mL-1 into a 
Superdex 200 PC 3.2/30 gel filtration column 
(GE Healthcare) pre-incubated with buffer (20 
mM Tris, 100 mM sodium chloride, pH 8.0), 
before being exposed to the X-ray beam through 
a 1.5 mm glass capillary at a continuous flow, 
with 2 seconds of X-ray exposure per image 
collected. 
Data reduction was performed using 
CHROMIXS (30), while data analysis was 
performed using the ATSAS software suite (31). 
Guinier and pairwise distribution analyses were 
performed using PrimusQT (32), while CRYSOL 
(33) was used to fit experimental data with 
theoretical scattering curves derived from 
crystallographic models. 
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Tables 
Table 1: Kinetic parameters of At-DAPDC1 and At-DAPDC2 
 Km (mM) Vmax (nmol.min-1) kcat (s-1) R2 
At-DAPDC1 5.1 (2.5–10.6) 85 (66–118) 0.005 0.97 
At-DAPDC2 4.8 (2.4–10.5) 229 (177–323) 0.014 0.98 
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Table 2: Sedimentation velocity fitting results for At-DAPDC1 and At-DAPDC2 to a reversible monomer-dimer 
equilibrium model. Values in parentheses represent 95% confidence intervals determined by conducting 96 
Monte Carlo iterations. The rmsd for the fits were 0.0043 and 0.0045. 
 At-DAPDC1 At-DAPDC2 
 Monomer Dimer Monomer Dimer 
Molecular weight (Da)# 53,807 107,614 54,240 108,480 
Sedimentation coefficient (S) 3.65 
(3.62–3.68) 
5.11 
(5.10–5.13) 
3.30 
(3.16–3.44) 
5.21 
(5.20–5.22) 
Frictional ratio (f/f0) 1.20 
(1.15–1.24) 
1.36 
(1.31–1.40) 
1.48 
(1.42–1.54) 
1.49 
(1.47–1.51) 
Dimer dissociation constant (KD2-1) µM 0.66 (0.56–0.76) 0.63 (0.53–0.74) 
# Molecular weight estimated from protein sequence in UltraScan 
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Table 3: Processing and refinement parameters. Values in parentheses pertain to the shell of highest resolution. 
 At-DAPDC1 At-DAPDC2 
Processing statistics   
Space group  P21212 P21 
Unit cell parameters, a, b, c (Å); β (°) 80.9, 121.5, 88.6; 90.0 51.3, 107.9, 80.3; 98.1 
Resolution range (Å) 42.62-1.88 (1.92-1.88) 39.77-2.35 (2.43-2.35) 
No. of measurements 525698 (31362) 132573 (11672) 
No. of unique reflections 71841 (4528) 35978 (3454) 
Redundancy 7.3 3.7 
Completeness (%)  99.9 (98.7) 99.7 (97.9) 
I/σ(I) 9.6 (1.5) 5.5 (1.3) 
CC1/2 0.997 (0.678) 0.987 (0.694) 
Rmerge 0.138 (1.197) 0.167 (0.824) 
Wilson B value (Å2) 22.2 34.0 
   
Refinement statistics   
Resolution (Å) 1.88 2.35 
Rwork 0.17 0.20 
Rfree 0.21 0.27 
No. of amino acid residues   436 440 
No. of water molecules 696 311 
No. others 4 2 
Mean refined B (Å2)   
   Protein 26.42 32.6 
   Ligands 16.99 33.77 
   Waters 35.02 28.59 
Rmsd from target values   
   Bond lengths (Å) 0.71 0.71 
   Bond angles (°) 0.84 0.84 
Ramachandran    
   Most favoured (%) 96.7 95.8 
   Allowed (%) 3.0 4.1 
   Disallowed (%) 0.2 0.1 
PDB entry 6N2A 6N2F 
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Table 4: Small-angle X-ray scattering structural parameters. 
 At-DAPDC1 At-DAPDC2 
I(0) (cm-1) (from Guinier) 0.0320 ± 0.0001 0.0600 ± 0.0001 
Guinier Rg/I(0) 34.74 ± 0.03 35.59 ± 0.06 
P(r) Rg/I(0) 34.77 ± 0.03 35.64 ± 0.06 
Dmax (Å) 105 113 
Porod volume (Å3) 161 000 160 000 
Molecular weight determination 
(kDa) (from Porod volume) 
94 706 94 118 
Calculated dimer molecular 
weight from sequence (kDa) 
107 608 108480 
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Figures 
 
 
Figure 1: Reaction catalyzed by DAPDC. Meso-diaminopimelate contains two stereocenters, D and L. DAPDC 
removes the carboxylate from the D-stereocenter to produce L-lysine. 
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Figure 2: Functional complementation analysis of an E. coli lysA mutant (CGSC strain #10193) using At-
DAPDC1 and At-DAPDC2. Colonies were replica-plated on media with lysine (A) or without lysine, 
supplemented with (B) glucose or (C) arabinose. 
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Figure 3: Enzyme kinetic analysis of At-DAPDC1 and At-DAPDC2. The catalytic activity was assessed using 
the DAPDC-SDH coupled assay (19). A) The rate of reaction relative to enzyme concentration shows the 
expected linear response between 200-800 nM for both At-DAPDC1 and At-DAPDC2.  Given this plot, the 
concentration of enzyme used for the initial rate experiments (B and C) was 550 nM, since this was in the linear 
range.  B) and C) The data (circles) represent the activity of At-DAPDC as a function of substrate (meso-
diaminopimelate) concentration, fitted to the Michaelis-Menten equation (solid line). The R2 for the fit to At-
DAPDC1 initial rate data was 97% and the fit to the At-DAPDC2 initial rate data was 98%. The green dashed 
lines indicate Km, while the red dashed lines indicate Vmax.   
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Figure 4: Sedimentation velocity analysis of At-DAPDC1 and At-DAPDC2. Continuous sedimentation 
coefficient (s20,W) distributions for A) At-DAPDC1 and B) At-DAPDC2 at 5 µM (black line), 10 µM (red line) 
and 20 µM (blue line). Enhanced van-Holde/Weischet analyses for C) At-DAPDC1 and D) At-DAPDC2 at 5 µM 
(black squares), 10 µM (red circles) and 20 µM (blue triangles). 
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Figure 5: A) Crystal structure of dimers of At-DAPDC1 (grey, PDB: 6N2A) and At-DAPDC2 (separate chains 
coloured in blue and green, PDB: 6N2F). B) A monomer of At-DAPDC1: the alanine racemase-like domain is 
coloured in yellow, while the (α/β)8 barrel domain is coloured in red. Small-angle X-ray scattering profile of C) 
At-DAPDC1 and D) At-DAPDC2 in solution compared to the theoretical scattering calculated based on the 
crystal structure of a monomer and a dimer of each protein. 
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Figure 6: Omit maps for A) the active site of At-DAPDC1 (active site shown is representative of both active 
sites) and B) the PLP/lysine-bound At-DAPDC2 active site. Fo-Fc electron density map shown in blue, contoured 
at 1.0 σ, 2Fo-Fc map shown in red and green to indicate negative and positive electron density, contoured at 3.0 
σ. PLP, free lysine, Lys77 residue (At-DAPDC1) and Lys81 residue (At-DAPDC2) shown as yellow sticks while 
the rest of protein is shown in cartoon form with one chain coloured grey and the other chain coloured cyan. C) 
PLP and D) lysine binding residues for At-DAPDC2.  
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Figure 7: Active site loop of A) At-DAPDC1 and B) At-DAPDC2. PLP molecule shown in purple to indicate 
location of active site. In both monomers of At-DAPDC1 the active site loop is closed over the active site. In the 
apo monomer of At-DAPDC2 (shown in blue) the active site loop is in an open conformation. C) Conformational 
changes in the active site between the PLP-bound (green sticks) and apo (blue sticks) monomers of At-DAPDC2. 
D) When meso-diaminopimelate is modelled in the same position as L-lysine, the carboxylate of the D-
stereocenter is positioned close enough to form a hydrogen bond with residue His220.  
 
 
